SOPHiA GENETICS SA (SOPH)

SOPHiA GENETICS experienced significant insider selling over the past 90 days, totaling nearly 6 million USD. Executives, including the Chief Scientific and Medical Officers, executed multiple planned divestments. This activity follows a 49.3% stock price increase, occurring despite a recent earnings report that missed expectations by 73.3%.
Ticker: SOPH Exchange: NSM


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for SOPHiA GENETICS SA. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Muken Ross Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
365.03
Quantity 54,632 -46.9%
Value US$374,455
2.1
CARDOZA GEORGE Chief Financial Officer Officer
Transaction date
Planned sale
Price
445.17
Quantity 73,620 +29.2%
Value US$1,187,339
2.1
GEORGE CARDOZA Officer Officer
Transaction date
Proposed sale
Price
215.35
Quantity 40,460
Value US$1,738,299
ROSS J MUKEN Director; Officer Executive Director
Transaction date
Proposed sale
Price
8.19
Quantity 1,000
Value US$100,000
Xu Zhenyu Chief Scientific Officer Officer
Transaction date
Planned sale
Price
7.88
Quantity 1,000 -0.7%
Value US$100,000
Menu Philippe Chief Medical Officer Officer
Transaction date
Planned sale
Price
7.88
Quantity 1,000 -2.3%
Value US$100,000
Van Well Daan Chief Legal Officer Officer
Transaction date
Planned sale
Price
7.63
Quantity 1,000 -1.8%
Value US$100,000
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
7.66
Quantity 1,000 -0.2%
Value US$100,000
HIBBS KATHY L Non-Executive Director
Transaction date
Planned sale
Price
8.13
Quantity 6,250 -6.1%
Value US$50,818
HIBBS KATHY L Non-Executive Director
Transaction date
Planned sale
Price
8.13
Quantity 6,250 -6.1%
Value US$50,818
Xu Zhenyu Chief Scientific Officer Officer
Transaction date
Planned sale
Price
8.91
Quantity 10,000 -1.8%
Value US$89,096
ZHENYU XU Officer Officer
Transaction date
Proposed sale
Price
8.53
Quantity 14,000
Value US$119,420
HIBBS KATHY L Non-Executive Director
Transaction date
Planned sale
Price
8.68
Quantity 6,250 -5.7%
Value US$54,233
Menu Philippe Chief Medical Officer Officer
Transaction date
Planned sale
Price
8.68
Quantity 5,000 -2.3%
Value US$43,396
KATHY L HIBBS Director Non-Executive Director
Transaction date
Proposed sale
Price
8.45
Quantity 18,750
Value US$158,438
Verma Abhimanyu Chief Technology Officer Officer
Transaction date
Planned sale
Price
8.80
Quantity 5,000 -2.8%
Value US$44,000
Xu Zhenyu Chief Scientific Officer Officer
Transaction date
Planned sale
Price
8.40
Quantity 5,408 -0.9%
Value US$45,447
Xu Zhenyu Chief Scientific Officer Officer
Transaction date
Planned sale
Price
8.41
Quantity 4,592 -0.8%
Value US$38,609
ZHENYU XU Officer Officer
Transaction date
Proposed sale
Price
8.28
Quantity 6,000
Value US$49,680
Verma Abhimanyu Chief Technology Officer Officer
Transaction date
Planned sale
Price
8.20
Quantity 5,000 -2.7%
Value US$41,000
Xu Zhenyu Chief Scientific Officer Officer
Transaction date
Planned sale
Price
7.94
Quantity 10,000 -1.7%
Value US$79,427
Valente Manuela Chief People Officer Officer
Transaction date
Planned sale
Price
7.94
Quantity 10,000 -4.5%
Value US$79,439
MANUELA VALENTE Officer Officer
Transaction date
Proposed sale
Price
7.62
Quantity 10,000
Value US$76,200
ZHENYU XU Officer Officer
Transaction date
Proposed sale
Price
7.62
Quantity 8,000
Value US$60,960
Xu Zhenyu Chief Scientific Officer Officer
Transaction date
Planned sale
Price
7.52
Quantity 4,000 -0.7%
Value US$30,076
Menu Philippe Chief Medical Officer Officer
Transaction date
Planned sale
Price
7.52
Quantity 5,000 -2.2%
Value US$37,580
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
7.61
Quantity 8,500 -0.2%
Value US$64,669
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
7.23
Quantity 20,000 -0.6%
Value US$144,540
Verma Abhimanyu Chief Technology Officer Officer
Transaction date
Planned sale
Price
7.60
Quantity 5,000 -2.7%
Value US$38,000
Xu Zhenyu Chief Scientific Officer Officer
Transaction date
Planned sale
Price
7.48
Quantity 10,000 -1.7%
Value US$74,759
Xu Zhenyu Chief Scientific Officer Officer
Transaction date
Planned sale
Price
7.02
Quantity 7,000 -1.2%
Value US$49,152
ZHENYU XU Officer Officer
Transaction date
Proposed sale
Price
6.69
Quantity 22,000
Value US$147,180
JURGI CAMBLONG Director; Officer Executive Director
Transaction date
Proposed sale
Price
6.69
Quantity 20,000
Value US$133,800
Xu Zhenyu Chief Scientific Officer Officer
Transaction date
Planned sale
Price
7.00
Quantity 3,000 -0.5%
Value US$21,013
Xu Zhenyu Chief Scientific Officer Officer
Transaction date
Planned sale
Price
6.92
Quantity 10,000 -1.6%
Value US$69,168
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
6.92
Quantity 20,000 -0.6%
Value US$138,412
Verma Abhimanyu Chief Technology Officer Officer
Transaction date
Planned sale
Price
6.95
Quantity 5,000 -2.6%
Value US$34,772
ZHENYU XU Officer Officer
Transaction date
Proposed sale
Price
5.69
Quantity 10,000
Value US$56,900
JURGI CAMBLONG Director; Officer Executive Director
Transaction date
Proposed sale
Price
5.69
Quantity 20,000
Value US$113,800
Menu Philippe Chief Medical Officer Officer
Transaction date
Planned sale
Price
5.66
Quantity 5,000 -2.2%
Value US$28,306
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
6.63
Quantity 20,000 -0.6%
Value US$132,654
JURGI CAMBLONG Director; Officer Executive Director
Transaction date
Proposed sale
Price
6.33
Quantity 37,000
Value US$234,210
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
6.17
Quantity 4,581 -0.1%
Value US$28,244
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
6.32
Quantity 19,800 -0.6%
Value US$125,201
JURGI CAMBLONG Director; Officer Executive Director
Transaction date
Proposed sale
Price
5.87
Quantity 24,381
Value US$143,116
Menu Philippe Chief Medical Officer Officer
Transaction date
Planned sale
Price
5.70
Quantity 5,000 -2.1%
Value US$28,505
Xu Zhenyu Chief Scientific Officer Officer
Transaction date
Planned sale
Price
5.70
Quantity 4,000 -0.7%
Value US$22,819
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
5.62
Quantity 8,500 -0.2%
Value US$47,791
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
5.28
Quantity 17,685 -0.5%
Value US$93,327
JURGI CAMBLONG Director; Officer Executive Director
Transaction date
Proposed sale
Price
5.34
Quantity 24,290
Value US$129,709
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
5.26
Quantity 22,486 -0.6%
Value US$118,164
Valente Manuela Chief People Officer Officer
Transaction date
Planned sale
Price
5.05
Quantity 4,241 -2.0%
Value US$21,430
2.1
CARDOZA GEORGE Chief Financial Officer Officer
Transaction date
Planned sale
Price
5.29
Quantity 1,592 -0.5%
Value US$8,419
Menu Philippe Chief Medical Officer Officer
Transaction date
Planned sale
Price
5.16
Quantity 7,393 -3.1%
Value US$38,156
Muken Ross Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
5.22
Quantity 9,838 -1.4%
Value US$51,354
Xu Zhenyu Chief Scientific Officer Officer
Transaction date
Planned sale
Price
5.17
Quantity 7,393 -1.2%
Value US$38,242
1.5
Puylaert Kevin Chief Sales Officer Officer
Transaction date
Sale
Price
5.09
Quantity 31 -0.0%
Value US$158
1.5
Puylaert Kevin Chief Sales Officer Officer
Transaction date
Sale
Price
5.03
Quantity 47 -0.0%
Value US$236
1.5
Puylaert Kevin Chief Sales Officer Officer
Transaction date
Sale
Price
5.03
Quantity 138 -0.1%
Value US$693
Verma Abhimanyu Chief Technology Officer Officer
Transaction date
Planned sale
Price
5.10
Quantity 5,285 -2.7%
Value US$26,957
PHILIPPE MENU Officer Officer
Transaction date
Proposed sale
Price
5.35
Quantity 32,393
Value US$173,303
ZHENYU XU Officer Officer
Transaction date
Proposed sale
Price
5.35
Quantity 19,393
Value US$103,753
2.1
GEORGE CARDOZA Officer Officer
Transaction date
Proposed sale
Price
5.35
Quantity 1,592
Value US$8,517
ROSS J MUKEN Officer Officer
Transaction date
Proposed sale
Price
5.35
Quantity 9,838
Value US$52,633
MANUELA VALENTE Officer Officer
Transaction date
Proposed sale
Price
5.35
Quantity 4,241
Value US$22,689
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
6.30
Quantity 200 -0.0%
Value US$1,260
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
6.02
Quantity 19,650 -0.5%
Value US$118,322
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
6.14
Quantity 45,419 -1.2%
Value US$279,050
JURGI CAMBLONG Director; Officer Executive Director
Transaction date
Proposed sale
Price
5.98
Quantity 70,000
Value US$418,600
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
6.00
Quantity 350 -0.0%
Value US$2,100
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
5.87
Quantity 18,060 -0.5%
Value US$105,958
JURGI CAMBLONG Director; Officer Executive Director
Transaction date
Proposed sale
Price
5.75
Quantity 20,000
Value US$115,000
Camblong Jurgi Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
5.84
Quantity 31,940 -0.9%
Value US$186,395
Camblong Jurgi Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
5.73
Quantity 18,129 -0.5%
Value US$103,934
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-09-22 2026-09-21 PlS Planned sale

Chief Executive Officer

Executive Director
54,632 -46.9%
365.03
US$374,455
54,632 -46.9% 365.03 US$374,455
2026-09-22 2026-09-21 PlS Planned sale

Chief Financial Officer

Officer
73,620 +29.2%
445.17
US$1,187,339
73,620 +29.2% 445.17 US$1,187,339
2026-09-21 2026-09-21 PrS Proposed sale

Officer

Officer
40,460
215.35
US$1,738,299
40,460 215.35 US$1,738,299
2026-09-21 2026-09-21 PrS Proposed sale

Director; Officer

Executive Director
1,000
8.19
US$100,000
1,000 8.19 US$100,000
2026-09-16 2026-09-14 PlS Planned sale

Chief Scientific Officer

Officer
1,000 -0.7%
7.88
US$100,000
1,000 -0.7% 7.88 US$100,000
2026-09-16 2026-09-14 PlS Planned sale

Chief Medical Officer

Officer
1,000 -2.3%
7.88
US$100,000
1,000 -2.3% 7.88 US$100,000
2026-09-14 2026-09-11 PlS Planned sale

Chief Legal Officer

Officer
1,000 -1.8%
7.63
US$100,000
1,000 -1.8% 7.63 US$100,000
2026-09-11 2026-09-11 PrS Proposed sale

Officer

Officer
6,168
7.61
US$46,938
6,168 7.61 US$46,938
2026-09-14 2026-09-10 PlS Planned sale

Executive Chairman

Executive Director
1,000 -0.2%
7.66
US$100,000
1,000 -0.2% 7.66 US$100,000
2026-09-10 2026-09-08 PlS Planned sale Non-Executive Director
6,250 -6.1%
8.13
US$50,818
6,250 -6.1% 8.13 US$50,818
2026-09-10 2026-09-08 PlS Planned sale Non-Executive Director
6,250 -6.1%
8.13
US$50,818
6,250 -6.1% 8.13 US$50,818
2026-08-31 2026-08-27 PlS Planned sale

Chief Scientific Officer

Officer
10,000 -1.8%
8.91
US$89,096
10,000 -1.8% 8.91 US$89,096
2026-08-27 2026-08-27 PrS Proposed sale

Officer

Officer
14,000
8.53
US$119,420
14,000 8.53 US$119,420
2026-08-26 2026-08-25 PlS Planned sale Non-Executive Director
6,250 -5.7%
8.68
US$54,233
6,250 -5.7% 8.68 US$54,233
2026-08-26 2026-08-25 PlS Planned sale

Chief Medical Officer

Officer
5,000 -2.3%
8.68
US$43,396
5,000 -2.3% 8.68 US$43,396
2026-08-25 2026-08-25 PrS Proposed sale

Director

Non-Executive Director
18,750
8.45
US$158,438
18,750 8.45 US$158,438
2026-08-26 2026-08-24 PlS Planned sale

Chief Technology Officer

Officer
5,000 -2.8%
8.80
US$44,000
5,000 -2.8% 8.80 US$44,000
2026-08-21 2026-08-21 PlS Planned sale

Chief Scientific Officer

Officer
5,408 -0.9%
8.40
US$45,447
5,408 -0.9% 8.40 US$45,447
2026-08-21 2026-08-20 PlS Planned sale

Chief Scientific Officer

Officer
4,592 -0.8%
8.41
US$38,609
4,592 -0.8% 8.41 US$38,609
2026-08-20 2026-08-20 PrS Proposed sale

Officer

Officer
6,000
8.28
US$49,680
6,000 8.28 US$49,680
2026-08-26 2026-08-19 PlS Planned sale

Chief Technology Officer

Officer
5,000 -2.7%
8.20
US$41,000
5,000 -2.7% 8.20 US$41,000
2026-08-21 2026-08-19 PlS Planned sale

Chief Scientific Officer

Officer
10,000 -1.7%
7.94
US$79,427
10,000 -1.7% 7.94 US$79,427
2026-08-21 2026-08-19 PlS Planned sale

Chief People Officer

Officer
10,000 -4.5%
7.94
US$79,439
10,000 -4.5% 7.94 US$79,439
2026-08-19 2026-08-19 PrS Proposed sale

Officer

Officer
10,000
7.62
US$76,200
10,000 7.62 US$76,200
2026-08-19 2026-08-19 PrS Proposed sale

Officer

Officer
8,000
7.62
US$60,960
8,000 7.62 US$60,960
2026-08-14 2026-08-13 PlS Planned sale

Chief Scientific Officer

Officer
4,000 -0.7%
7.52
US$30,076
4,000 -0.7% 7.52 US$30,076
2026-08-14 2026-08-12 PlS Planned sale

Chief Medical Officer

Officer
5,000 -2.2%
7.52
US$37,580
5,000 -2.2% 7.52 US$37,580
2026-08-10 2026-08-10 PlS Planned sale

Executive Chairman

Executive Director
8,500 -0.2%
7.61
US$64,669
8,500 -0.2% 7.61 US$64,669
2026-08-10 2026-08-07 PlS Planned sale

Executive Chairman

Executive Director
20,000 -0.6%
7.23
US$144,540
20,000 -0.6% 7.23 US$144,540
2026-08-10 2026-08-07 PlS Planned sale

Chief Technology Officer

Officer
5,000 -2.7%
7.60
US$38,000
5,000 -2.7% 7.60 US$38,000
2026-08-07 2026-08-07 PlS Planned sale

Chief Scientific Officer

Officer
10,000 -1.7%
7.48
US$74,759
10,000 -1.7% 7.48 US$74,759
2026-08-07 2026-08-07 PlS Planned sale

Chief Scientific Officer

Officer
7,000 -1.2%
7.02
US$49,152
7,000 -1.2% 7.02 US$49,152
2026-08-07 2026-08-07 PrS Proposed sale

Officer

Officer
22,000
6.69
US$147,180
22,000 6.69 US$147,180
2026-08-07 2026-08-07 PrS Proposed sale

Director; Officer

Executive Director
20,000
6.69
US$133,800
20,000 6.69 US$133,800
2026-08-07 2026-08-05 PlS Planned sale

Chief Scientific Officer

Officer
3,000 -0.5%
7.00
US$21,013
3,000 -0.5% 7.00 US$21,013
2026-08-05 2026-08-04 PlS Planned sale

Chief Scientific Officer

Officer
10,000 -1.6%
6.92
US$69,168
10,000 -1.6% 6.92 US$69,168
2026-08-05 2026-08-04 PlS Planned sale

Executive Chairman

Executive Director
20,000 -0.6%
6.92
US$138,412
20,000 -0.6% 6.92 US$138,412
2026-08-05 2026-08-04 PlS Planned sale

Chief Technology Officer

Officer
5,000 -2.6%
6.95
US$34,772
5,000 -2.6% 6.95 US$34,772
2026-08-04 2026-08-04 PrS Proposed sale

Officer

Officer
10,000
5.69
US$56,900
10,000 5.69 US$56,900
2026-08-04 2026-08-04 PrS Proposed sale

Director; Officer

Executive Director
20,000
5.69
US$113,800
20,000 5.69 US$113,800
2026-07-28 2026-07-27 PlS Planned sale

Chief Medical Officer

Officer
5,000 -2.2%
5.66
US$28,306
5,000 -2.2% 5.66 US$28,306
2026-07-22 2026-07-21 PlS Planned sale

Executive Chairman

Executive Director
20,000 -0.6%
6.63
US$132,654
20,000 -0.6% 6.63 US$132,654
2026-07-21 2026-07-21 PrS Proposed sale

Director; Officer

Executive Director
37,000
6.33
US$234,210
37,000 6.33 US$234,210
2026-07-22 2026-07-20 PlS Planned sale

Executive Chairman

Executive Director
4,581 -0.1%
6.17
US$28,244
4,581 -0.1% 6.17 US$28,244
2026-07-22 2026-07-20 PlS Planned sale

Executive Chairman

Executive Director
19,800 -0.6%
6.32
US$125,201
19,800 -0.6% 6.32 US$125,201
2026-07-20 2026-07-20 PrS Proposed sale

Director; Officer

Executive Director
24,381
5.87
US$143,116
24,381 5.87 US$143,116
2026-07-14 2026-07-13 PlS Planned sale

Chief Medical Officer

Officer
5,000 -2.1%
5.70
US$28,505
5,000 -2.1% 5.70 US$28,505
2026-07-14 2026-07-13 PlS Planned sale

Chief Scientific Officer

Officer
4,000 -0.7%
5.70
US$22,819
4,000 -0.7% 5.70 US$22,819
2026-07-14 2026-07-10 PlS Planned sale

Executive Chairman

Executive Director
8,500 -0.2%
5.62
US$47,791
8,500 -0.2% 5.62 US$47,791
2026-07-08 2026-07-07 PlS Planned sale

Executive Chairman

Executive Director
17,685 -0.5%
5.28
US$93,327
17,685 -0.5% 5.28 US$93,327
2026-07-07 2026-07-07 PrS Proposed sale

Director; Officer

Executive Director
24,290
5.34
US$129,709
24,290 5.34 US$129,709
2026-07-07 2026-07-06 PlS Planned sale

Executive Chairman

Executive Director
22,486 -0.6%
5.26
US$118,164
22,486 -0.6% 5.26 US$118,164
2026-07-07 2026-07-06 PlS Planned sale

Chief People Officer

Officer
4,241 -2.0%
5.05
US$21,430
4,241 -2.0% 5.05 US$21,430
2026-07-07 2026-07-06 PlS Planned sale

Chief Financial Officer

Officer
1,592 -0.5%
5.29
US$8,419
1,592 -0.5% 5.29 US$8,419
2026-07-07 2026-07-06 PlS Planned sale

Chief Medical Officer

Officer
7,393 -3.1%
5.16
US$38,156
7,393 -3.1% 5.16 US$38,156
2026-07-07 2026-07-06 PlS Planned sale

Chief Executive Officer

Executive Director
9,838 -1.4%
5.22
US$51,354
9,838 -1.4% 5.22 US$51,354
2026-07-07 2026-07-06 PlS Planned sale

Chief Scientific Officer

Officer
7,393 -1.2%
5.17
US$38,242
7,393 -1.2% 5.17 US$38,242
2026-07-07 2026-07-06 S Sale

Chief Sales Officer

Officer
31 -0.0%
5.09
US$158
31 -0.0% 5.09 US$158
2026-07-07 2026-07-06 S Sale

Chief Sales Officer

Officer
47 -0.0%
5.03
US$236
47 -0.0% 5.03 US$236
2026-07-07 2026-07-06 S Sale

Chief Sales Officer

Officer
138 -0.1%
5.03
US$693
138 -0.1% 5.03 US$693
2026-07-07 2026-07-06 PlS Planned sale

Chief Technology Officer

Officer
5,285 -2.7%
5.10
US$26,957
5,285 -2.7% 5.10 US$26,957
2026-07-06 2026-07-06 PrS Proposed sale

Officer

Officer
32,393
5.35
US$173,303
32,393 5.35 US$173,303
2026-07-06 2026-07-06 PrS Proposed sale

Officer

Officer
19,393
5.35
US$103,753
19,393 5.35 US$103,753
2026-07-06 2026-07-06 PrS Proposed sale

Officer

Officer
1,592
5.35
US$8,517
1,592 5.35 US$8,517
2026-07-06 2026-07-06 PrS Proposed sale

Officer

Officer
9,838
5.35
US$52,633
9,838 5.35 US$52,633
2026-07-06 2026-07-06 PrS Proposed sale

Officer

Officer
4,241
5.35
US$22,689
4,241 5.35 US$22,689
2026-07-01 2026-06-30 PlS Planned sale

Executive Chairman

Executive Director
200 -0.0%
6.30
US$1,260
200 -0.0% 6.30 US$1,260
2026-07-01 2026-06-30 PlS Planned sale

Executive Chairman

Executive Director
19,650 -0.5%
6.02
US$118,322
19,650 -0.5% 6.02 US$118,322
2026-07-01 2026-06-30 PlS Planned sale

Executive Chairman

Executive Director
45,419 -1.2%
6.14
US$279,050
45,419 -1.2% 6.14 US$279,050
2026-06-30 2026-06-30 PrS Proposed sale

Director; Officer

Executive Director
70,000
5.98
US$418,600
70,000 5.98 US$418,600
2026-07-01 2026-06-29 PlS Planned sale

Executive Chairman

Executive Director
350 -0.0%
6.00
US$2,100
350 -0.0% 6.00 US$2,100
2026-07-01 2026-06-29 PlS Planned sale

Executive Chairman

Executive Director
18,060 -0.5%
5.87
US$105,958
18,060 -0.5% 5.87 US$105,958
2026-06-29 2026-06-29 PrS Proposed sale

Director; Officer

Executive Director
20,000
5.75
US$115,000
20,000 5.75 US$115,000
2026-06-29 2026-06-26 PlS Planned sale

Chief Executive Officer

Executive Director
31,940 -0.9%
5.84
US$186,395
31,940 -0.9% 5.84 US$186,395
2026-06-29 2026-06-26 PlS Planned sale

Chief Executive Officer

Executive Director
18,129 -0.5%
5.73
US$103,934
18,129 -0.5% 5.73 US$103,934